That is great news. The article mentions the
Post# of 150221
(Total Views: 456)
Posted On: 11/04/2021 12:54:25 PM
That is great news.
The article mentions the use of a diagnostic test developed by Creatv MicroTech.
Is that new or relevant? (New to me but might have been missing it.)
CytoDyn Results on 12-Month Analysis of Metastatic Triple-Negative Breast Cancer Patients
These results were determined by the LifeTracDx test developed by Creatv MicroTech, Inc., which test appears to aid as a parallel diagnostic tool in identifying patients that respond to leronlimab.
TIA
__________________
Posted By: Figgs
Nice article, great news:
https://trialsitenews.com/cytodyn-reports-12-...-survival/
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼